Mediastinal Lymph Node Metastasis from Head and Neck Cancer: Predictive Factors and Imaging Features

Area of Science:

• Oncology
• Radiology
• Head and Neck Surgery

Background:

• Head and neck cancers frequently metastasize to regional lymph nodes.
• Mediastinal lymph node (MLN) involvement signifies advanced disease and impacts prognosis.
• Predictive factors and imaging characteristics of MLN metastasis require further elucidation.

Purpose of the Study:

• To identify clinical and disease characteristics predicting mediastinal lymph node (MLN) metastasis in head and neck cancer patients.
• To describe the imaging features of MLN metastases using chest CT and PET/CT.

Main Methods:

• Retrospective comparison of clinical features and disease characteristics between patients with and without MLN metastasis.
• Analysis of chest CT and PET/CT findings, including lymph node distribution, size, and standardized uptake value (SUV).

Main Results:

• 11.7% of 470 head and neck cancer patients had MLN metastasis.
• Significant predictors included hypopharynx cancer, recurrent tumor, T4, N2/N3, and M1 stages.
• Most common MLN sites were ipsilateral station 2 (upper paratracheal), station 11 (interlobar), and station 10 (hilar).

Conclusions:

• Mediastinal lymph node metastasis is a critical consideration in head and neck cancer management.
• High-risk patient groups include those with hypopharyngeal tumors, recurrent disease, and advanced TNM staging.
• Radiological assessment of MLNs is essential for accurate staging and treatment planning.